会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明授权
    • Pharmaceutical compositions
    • 药物组合物
    • US08367735B2
    • 2013-02-05
    • US12375208
    • 2007-07-26
    • Stanley M. RobertsGabriella M. Santoro
    • Stanley M. RobertsGabriella M. Santoro
    • A61K31/015A61K31/12C07C49/603
    • C07C49/753C07C45/74C07C323/59C07F7/1804
    • The present invention relates to compounds of formula I or II:—wherein R is an alkyl, alkenyl, alkynyl, aryl, aralkyl, aralkenyl, or aralkynyl group, that may be substituted or unsubstituted, and that optionally includes at least one heteroatom in its carbon skeleton; R1 is hydrogen, or an alkyl, substituted alkyl, alkenyl, alkynyl, aryl, substituted aryl, or aralkyl group; and R2 is an alkyl, alkenyl, alkynyl, aryl, aralkyl, aralkenyl, or aralkynyl group containing 4-12 carbon atoms, that may be substituted or unsubstituted, and that optionally includes at least one heteroatom in its carbon skeleton; provided that in a compound of formula I, when R1 is an iso-propyl or phenyl group, R2 is not an acetyl or tert-butyldimethylsilyl group; and their use in therapeutic, diagnostic and research methods.
    • 本发明涉及式I或II的化合物:其中R是烷基,烯基,炔基,芳基,芳烷基,芳烯基或芳炔基,其可以是取代或未取代的,并且其任选地在其中包含至少一个杂原子 碳骨架 R1是氢或烷基,取代的烷基,烯基,炔基,芳基,取代的芳基或芳烷基; 并且R 2是可以被取代或未取代的含有4-12个碳原子的烷基,烯基,炔基,芳基,芳烷基,芳烯基或芳炔基,并且其任选地在其碳骨架中包含至少一个杂原子; 条件是在式I化合物中,当R 1是异丙基或苯基时,R 2不是乙酰基或叔丁基二甲基甲硅烷基; 及其在治疗,诊断和研究方法中的应用。